Skip to main navigation Skip to search Skip to main content

A Phase II, Double-Blind, Randomized, Exploratory, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of MCC-135 Comparing QD vs BID Doses in Subjects with Congestive Heart Failure, NYHA Class II/III

Project: Research

Project Details

StatusFinished
Effective start/end date11/2/02 → 10/31/04

Funding

  • Omnicare Clinical Research: $14,194.40